Cargando…
Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
Novel technologies that include recombinant pathogens and rapid detection methods are contributing to the development of drugs for neglected diseases. Recently, the results from the first high throughput screening (HTS) to test compounds for activity against Trypanosoma cruzi trypomastigote infectio...
Autores principales: | Andriani, Grasiella, Chessler, Anne-Danielle C., Courtemanche, Gilles, Burleigh, Barbara A., Rodriguez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166044/ https://www.ncbi.nlm.nih.gov/pubmed/21912715 http://dx.doi.org/10.1371/journal.pntd.0001298 |
Ejemplares similares
-
Correction: Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
Publicado: (2014) -
In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
por: Canavaci, Adriana M. C., et al.
Publicado: (2010) -
High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014) -
Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021) -
Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies
por: Soeiro, Maria de Nazaré C, et al.
Publicado: (2011)